CN101791388A - Traditional Chinese medicine preparation for treating peptic ulcer - Google Patents
Traditional Chinese medicine preparation for treating peptic ulcer Download PDFInfo
- Publication number
- CN101791388A CN101791388A CN201010144044A CN201010144044A CN101791388A CN 101791388 A CN101791388 A CN 101791388A CN 201010144044 A CN201010144044 A CN 201010144044A CN 201010144044 A CN201010144044 A CN 201010144044A CN 101791388 A CN101791388 A CN 101791388A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- fructus
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 53
- 208000008469 Peptic Ulcer Diseases 0.000 title claims abstract description 28
- 208000011906 peptic ulcer disease Diseases 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 241000218176 Corydalis Species 0.000 claims abstract description 13
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 13
- 241001522129 Pinellia Species 0.000 claims abstract description 7
- 241000628997 Flos Species 0.000 claims description 18
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 12
- 241000180649 Panax notoginseng Species 0.000 claims description 12
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 12
- 210000003038 endothelium Anatomy 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 11
- 241001346334 Amomum tsao-ko Species 0.000 claims description 6
- 241000180579 Arca Species 0.000 claims description 6
- 241000245240 Lonicera Species 0.000 claims description 6
- 241000238370 Sepia Species 0.000 claims description 6
- 241001078983 Tetradium ruticarpum Species 0.000 claims description 6
- 201000003639 autosomal recessive cerebellar ataxia Diseases 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 18
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 241001127714 Amomum Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241001313855 Bletilla Species 0.000 abstract 1
- 241001233914 Chelidonium majus Species 0.000 abstract 1
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 abstract 1
- 241000099774 Cuscuta salina Species 0.000 abstract 1
- 241000735527 Eupatorium Species 0.000 abstract 1
- 241000287828 Gallus gallus Species 0.000 abstract 1
- 244000167230 Lonicera japonica Species 0.000 abstract 1
- 235000017617 Lonicera japonica Nutrition 0.000 abstract 1
- 241001673966 Magnolia officinalis Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 241001339782 Scapharca broughtonii Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 25
- 230000036407 pain Effects 0.000 description 25
- 208000025865 Ulcer Diseases 0.000 description 24
- 210000002784 stomach Anatomy 0.000 description 22
- 231100000397 ulcer Toxicity 0.000 description 22
- 206010047700 Vomiting Diseases 0.000 description 16
- 230000008673 vomiting Effects 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 201000010099 disease Diseases 0.000 description 10
- 229940079593 drug Drugs 0.000 description 10
- 206010067171 Regurgitation Diseases 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 206010000087 Abdominal pain upper Diseases 0.000 description 7
- 208000001848 dysentery Diseases 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 208000007107 Stomach Ulcer Diseases 0.000 description 6
- 210000001015 abdomen Anatomy 0.000 description 6
- 208000000718 duodenal ulcer Diseases 0.000 description 6
- 201000005917 gastric ulcer Diseases 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 210000001156 gastric mucosa Anatomy 0.000 description 5
- 241000590002 Helicobacter pylori Species 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 210000000038 chest Anatomy 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 210000004211 gastric acid Anatomy 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 229940037467 helicobacter pylori Drugs 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 241000294743 Gamochaeta Species 0.000 description 3
- 208000007882 Gastritis Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 208000031361 Hiccup Diseases 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 208000002399 aphthous stomatitis Diseases 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 230000002183 duodenal effect Effects 0.000 description 3
- 210000003238 esophagus Anatomy 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000001047 pyretic effect Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 208000004300 Atrophic Gastritis Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010006326 Breath odour Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 206010053155 Epigastric discomfort Diseases 0.000 description 2
- 208000036495 Gastritis atrophic Diseases 0.000 description 2
- 208000032139 Halitosis Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010028116 Mucosal inflammation Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010057969 Reflux gastritis Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 230000009102 absorption Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 229940069428 antacid Drugs 0.000 description 2
- 239000003159 antacid agent Substances 0.000 description 2
- 230000001458 anti-acid effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 210000002318 cardia Anatomy 0.000 description 2
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 2
- 208000023652 chronic gastritis Diseases 0.000 description 2
- 210000000589 cicatrix Anatomy 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 206010013864 duodenitis Diseases 0.000 description 2
- 210000001198 duodenum Anatomy 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 206010016766 flatulence Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 2
- 208000007565 gingivitis Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 239000003485 histamine H2 receptor antagonist Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000004347 intestinal mucosa Anatomy 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 208000000689 peptic esophagitis Diseases 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 229940126409 proton pump inhibitor Drugs 0.000 description 2
- 239000000612 proton pump inhibitor Substances 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 210000002417 xiphoid bone Anatomy 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000270299 Boa Species 0.000 description 1
- 208000001387 Causalgia Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 206010013554 Diverticulum Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 208000014540 Functional gastrointestinal disease Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010017886 Gastroduodenal ulcer Diseases 0.000 description 1
- 208000033469 Gastrooesophageal heterotopia Diseases 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010054949 Metaplasia Diseases 0.000 description 1
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 108010047320 Pepsinogen A Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- VVWYOYDLCMFIEM-UHFFFAOYSA-N Propantheline Chemical compound C1=CC=C2C(C(=O)OCC[N+](C)(C(C)C)C(C)C)C3=CC=CC=C3OC2=C1 VVWYOYDLCMFIEM-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 201000000660 Pyloric Stenosis Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 208000008630 Sialorrhea Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001775 anti-pathogenic effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 208000006766 bile reflux Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 201000007637 bowel dysfunction Diseases 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 208000020670 canker sore Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000015864 chronic erosive gastritis Diseases 0.000 description 1
- 231100000749 chronicity Toxicity 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- DCSUBABJRXZOMT-IRLDBZIGSA-N cisapride Chemical compound C([C@@H]([C@@H](CC1)NC(=O)C=2C(=CC(N)=C(Cl)C=2)OC)OC)N1CCCOC1=CC=C(F)C=C1 DCSUBABJRXZOMT-IRLDBZIGSA-N 0.000 description 1
- 229960005132 cisapride Drugs 0.000 description 1
- DCSUBABJRXZOMT-UHFFFAOYSA-N cisapride Natural products C1CC(NC(=O)C=2C(=CC(N)=C(Cl)C=2)OC)C(OC)CN1CCCOC1=CC=C(F)C=C1 DCSUBABJRXZOMT-UHFFFAOYSA-N 0.000 description 1
- 208000014439 complex regional pain syndrome type 2 Diseases 0.000 description 1
- 230000008828 contractile function Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 230000030135 gastric motility Effects 0.000 description 1
- 231100000029 gastro-duodenal ulcer Toxicity 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003886 intestinal anastomosis Effects 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000009115 maintenance therapy Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000015689 metaplastic ossification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 229960000697 propantheline Drugs 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine preparation for treating peptic ulcer, which is prepared from the following traditional Chinese medicine materials in parts by weight: 1-5 parts of cuttlebone, 1-5 parts of officinal magnolia bark, 3-10 parts of fructus amomi, 1-5 parts of rhizoma corydalis, 3-10 parts of fortune eupatorium herb, 1-5 parts of costustoot, 1-5 parts of fried radix paeoniae alba, 3-10 parts of bletilla, 1-5 parts of japanesehoneysuckle, 1-5 parts of pseudo-ginseng, 5-10 parts of Chinese angelica, 3-10 parts of fingered citron, 1-5 parts of blood clam shell, 1-5 parts of dandelion, 3-10 parts of rehmanniae vaporata, 1-5 parts of golden thread, 1-5 parts of rhubarb, 1-5 parts of chicken's gizzardskin, 3-10 parts of indian buead, 1-5 parts of fructus evodiae, 1-5 parts of paniculate swallowwort root, 1-5 parts of pinellia tuber and 1-5 parts of tsaoko amomum fruit. The invention is used for treating peptic ulcer, is a pure traditional Chinese medicine preparation and has little toxic and side effect and high cure rate for treating peptic ulcer, and peptic ulcer can be cured within 1-2 courses of treating without relapse. The invention has wide medicine source and low cost, and is worthy of clinical generalization and application.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation, specifically, relate to a kind of Chinese medicine preparation that is used for the treatment of peptic ulcer.
Background technology
Peptic ulcer mainly refers to occur in the duodenal chronic ulcer of harmonization of the stomach, also can betide around the distal esophagus, stomach intestinal anastomosis mouth and contains Mei Keer (MECKEL) diverticulum of ectopic gastric mucosa.The formation of these ulcer is relevant with pepsic Digestion with gastric acid, so claim peptic ulcer.
In recent years the formation of discovering ulcer is relevant with the existence of helicobacter pylori (HP).The primary disease overwhelming majority (more than 95%) is positioned at the harmonization of the stomach duodenum, so claim gastroduodenal ulcer again.Further investigation shows that gastric ulcer and duodenal ulcer disease are having tangible difference aspect the cause of disease and the pathogenesis, be not with a kind of disease, but the performance of both epidemiology, symptom is basic identical.
The peptic ulcer symptom shows as:
1. chronic, periodically, epigastrium pain in the rhythmicity, gastric ulcer is everlasting under the xiphoid-process or is taken back, the back outbreak in 1-2 hour of having meal continues 1-2 hour stomach row back and alleviates; Duodenal ulcer is many to take under xiphoid-process, more than the alleviation of feed back takes place on an empty stomach.It is relevant with season to show effect.Pain character can be dull pain, causalgia or hungry sample pain.Cardia district, huge ulcer and multiple ulcer, plyability ulcer or when complication was arranged, stomachache can not be true to type, and tormina or hypnalgia can be arranged behind specific type ulcer such as pyloric canal, the ball, at the bottom of the stomach.
Often with return acid, belch, sialorrhea, feel sick, vomiting etc.
3. General Symptoms: the patient can have neurosal performances such as insomnia, and the acute and influence of pain is advanced the trencherman and can be become thin and anemia.
4. general no obvious sign of catabasis.Active stage boas point be everlasting in upper abdomen or take back; The duodenal ulcer person is everlasting and takes over; The rear wall penetrating ulcer is the 11st, 12 thoracic vertebra both sides at the back.
The peptic ulcer diagnosis basis is:
1. have chronic, rhythmicity, periodically in epigastrium pain.
2. can return acid, belch, feel sick, vomit and other dyspeptic symptoms.
3. gastroscope or upper digestive tract barium meal examination (GI) can be found niche.
The Therapeutic Principle of peptic ulcer is:
1. elimination symptom promotes ulcer healing;
2. prevention of recurrence and avoid complication;
3. wholistic therapy combines with topical therapeutic, chronicity and persistence that the medical treatment of being eager to excel is treated;
4. select effective, inexpensive, the easy to use and individuation of medicine;
5. operative treatment in case of necessity.
The principle of medication of peptic ulcer: 1. gastric ulcer and duodenal ulcer in the treatment existing identical outside, different place is also arranged.Identical point is killed HP at application antacid medicine (comprising H2 receptor blocking agent or proton pump inhibitor and general alkalescent medicine); Difference is that the treatment of gastric ulcer need be with promoting the gastric emptying medicine as fourth beautiful jade, cisapride etc., and duodenal ulcer then should not be used, and uses anticholinergic agent such as atropine, propantheline etc. more.The treatment of ulcer just control or the state of an illness than the lighter, can adopt the H2 receptor blocking agent earlier, invalid or intractable ulcer or have complication person to use proton pump inhibitor instead.3. can dialectically add with Chinese medicine or Chinese patent medicine.
The auxiliary examination of peptic ulcer: 1. the diagnosis of model case is based on check box limit " A "; 2. in the time of need differentiating or be suspected to have malignant change of benign gastric ulcer generation liver, lung and abdominal cavity transfer with liver and gall diseases, check that special project comprises check box limit " A ", " B ", " C ".
Expert's prompting: the formation and development of peptic ulcer is relevant with pepsic Digestion with the gastric acid in the gastric juice, so must guard against working on an empty stomach and go to bed on an empty stomach.(2-4 week) to make ulcer healing reach the cicatrix phase not difficult at short notice, and key is to prevent ulcer recurrence.Because malpractice, ulcer is shown effect repeatedly, can occur severe complications such as hemorrhage, perforation, pyloric obstruction and malignant change of benign gastric ulcer when serious, harm is bigger.
Common people think the Peptic Ulcers refractory, mainly are to fail correct, rational use of drug, adopt the way of " facing pain makes a hasty last " often, and careless medication during pain or not just does not go to comprehend, though this way can temporarily be proved effective, can only be to cure the symptoms, not the disease yet.Should correctly take the therapeutic dose medicine to reach after the regular hour again decrement and change the clothes maintenance dose and keep treatment, keep treatment and can be divided into long term maintenance and intermittently keep two kinds.The former takes continuous use half a year to one year or longer; The latter can not take medicine at ordinary times, when feeling epigastric discomfort or sending out previous month of season well in ulcer and take medicine.Treatment time 2-4 week.If can adhere to said method medication person, generally recur less.No matter adopt which kind of maintenance therapy, fibrous root is according to each one concrete condition and decide.In addition, give up bad life habits, reduce the stimulation of cigarette, wine, pungent, strong tea, coffee and some drugs, also significant to ulcer healing and prevention of recurrence.
Summary of the invention
The technical issues that need to address of the present invention just are to overcome the defective of prior art, and a kind of Chinese medicine preparation that is used for the treatment of peptic ulcer is provided, and it is a kind of pure Chinese medicinal preparation, toxic and side effects is little, be used for treatment of peptic ulcer cure rate height, 1-2 cures the course of treatment, few recurrence.Medicine of the present invention source is extensive, cost is low, be worth clinical application.
For addressing the above problem, the present invention adopts following technical scheme:
A kind of Chinese medicine preparation that is used for the treatment of peptic ulcer of the present invention, described Chinese medicine preparation is prepared from by following Chinese medicinal raw materials in portion by weight:
Endoconcha Sepiae 1-5 part, Cortex Magnoliae Officinalis 1-5 part, Fructus Amomi 3-10 part, Rhizoma Corydalis 1-5 part, Herba Eupatorii 3-10 part, Radix Aucklandiae 1-5 part, Radix Paeoniae Alba (parched) 1-5 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 3-10 part, Flos Lonicerae 1-5 part, Radix Notoginseng 1-5 part, Radix Angelicae Sinensis 5-10 part, Fructus Citri Sarcodactylis 3-10 part, Concha Arcae 1-5 part, Herba Taraxaci 1-5 part, Radix Rehmanniae Preparata 3-10 part, Rhizoma Coptidis 1-5 part, Radix Et Rhizoma Rhei 1-5 part, Endothelium Corneum Gigeriae Galli 1-5 part, Poria 3-10 part, Fructus Evodiae 1-5 part, Radix Cynanchi Paniculati 1-5 part, Rhizoma Pinelliae 1-5 part and Fructus Tsaoko 1-5 part.
Perhaps, described Chinese medicine preparation is prepared from by following Chinese medicinal raw materials in portion by weight:
1 part of Endoconcha Sepiae, 5 parts of Cortex Magnoliae Officinalis, 3 parts of Fructus Amomis, 5 parts of Rhizoma Corydalis, 3 parts of Herba Eupatoriis, 5 parts of the Radix Aucklandiae, 1 part of Radix Paeoniae Alba (parched), 10 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 1 part of Flos Lonicerae, 5 parts of Radix Notoginseng, 5 parts of Radix Angelicae Sinensis, 10 parts of Fructus Citri Sarcodactylis, 1 part of Concha Arcae, 5 parts of Herba Taraxacis, 3 parts in Radix Rehmanniae Preparata, 5 parts of Rhizoma Coptidis, 1 part of Radix Et Rhizoma Rhei, 5 parts of Endothelium Corneum Gigeriae Galli, 3 parts in Poria, 5 parts of Fructus Evodiaes, 1 part of Radix Cynanchi Paniculati, 1 part of 5 parts of the Rhizoma Pinelliaes and Fructus Tsaoko.
Perhaps, described Chinese medicine preparation is prepared from by following Chinese medicinal raw materials in portion by weight:
5 parts of Endoconcha Sepiaes, 1 part of Cortex Magnoliae Officinalis, 10 parts of Fructus Amomis, 1 part of Rhizoma Corydalis, 10 parts of Herba Eupatoriis, 1 part of the Radix Aucklandiae, 5 parts of Radix Paeoniae Alba (parched)s, 3 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 5 parts of Flos Loniceraes, 1 part of Radix Notoginseng, 10 parts of Radix Angelicae Sinensis, 3 parts of Fructus Citri Sarcodactylis, 5 parts of Concha Arcaes, 1 part of Herba Taraxaci, 10 parts in Radix Rehmanniae Preparata, 1 part of Rhizoma Coptidis, 5 parts of Radix Et Rhizoma Rhei, 1 part of Endothelium Corneum Gigeriae Galli, 10 parts in Poria, 1 part of Fructus Evodiae, 5 parts of Radix Cynanchi Paniculatis, 5 parts of 1 part of the Rhizoma Pinelliae and Fructus Tsaokos.
Perhaps, described Chinese medicine preparation is prepared from by following Chinese medicinal raw materials in portion by weight:
3 parts of Endoconcha Sepiaes, 3 parts of Cortex Magnoliae Officinalis, 6 parts of Fructus Amomis, 3 parts of Rhizoma Corydalis, 6 parts of Herba Eupatoriis, 3 parts of the Radix Aucklandiae, 3 parts of Radix Paeoniae Alba (parched)s, 6 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 3 parts of Flos Loniceraes, 3 parts of Radix Notoginseng, 10 parts of Radix Angelicae Sinensis, 6 parts of Fructus Citri Sarcodactylis, 3 parts of Concha Arcaes, 3 parts of Herba Taraxacis, 6 parts in Radix Rehmanniae Preparata, 3 parts of Rhizoma Coptidis, 3 parts of Radix Et Rhizoma Rhei, 3 parts of Endothelium Corneum Gigeriae Galli, 6 parts in Poria, 3 parts of Fructus Evodiaes, 3 parts of Radix Cynanchi Paniculatis, 3 parts of 3 parts of the Rhizoma Pinelliaes and Fructus Tsaokos.
Among the present invention:
Endoconcha Sepiae, dehumidifying, antacid, skin ulcer is held back in hemostasis.The acid regurgitation that treats for stomachache is told, nosebleed, hematemesis, has blood in stool, and bleeding not during menses, amenorrhea due to blood depletion, the stomachache lump in the abdomen, the intermittent fever of deficiency type dysentery, skin ulcer is rotted in the erosion of the vulva.
Cortex Magnoliae Officinalis is a damp-resolving medicinal, and performance is arduous warm, has the merit of dampness, and Chang Xiangxu is a usefulness, the card of treatment retention of dampness in middle-JIAO.Attach most importance to bitterness, it is full that hardship is fallen the gas removing stagnancy of indigested food and relieving flatulence, and therapeutic method to keep the adverse QI flowing downwards eliminating phlegm to relieve asthma both can remove invisible wet medicine again, and the tangible reality that can disappear again is full, for eliminating the key medicine of distension;
Fructus Amomi, the removing dampness appetizing, warming spleen and stopping diarrha.Be used for turbid damp obstructing in middle-JIAO, the gastral cavity painful abdominal mass is not hungry, Deficiency and coldness of spleen and stomach, and vomiting is had loose bowels.
Rhizoma Corydalis, warm in nature, the acrid in the mouth hardship is gone into the heart, spleen, liver, lung, is the quality goods of blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain, is world-famous for the effect of pain relieving especially.
Herba Eupatorii, removing dampness by means of aromatics, expelling summer-heat is delivered in the appetizing of being amusing.Be used for turbid damp obstructing in middle-JIAO, gastral cavity painful abdominal mass vomiting and nausea, mouthful sweet greasy, halitosis, sialism, heat-damp in summer table disease, feeling of fullness in the head is uncomfortable in chest.
The Radix Aucklandiae, promoting the circulation of QI to relieve pain, warming middle-JIAO for easing the stomach.Be used for chest and abdomen swelling and pain, the dysentery tenesmus is had loose bowels in vomiting.
The Radix Paeoniae Alba has antibacterial action.Nourishing blood to suppress the hyperactive liver, slow middle pain relieving, yin fluid astringing is received antiperspirant.Control the breast abdomen pain over the hypochondriac region, dysentery stomachache.
The Pseudobulbus Bletillae (Rhizoma Bletillae), hemostasia and promoting granulation.Control digestive tract hemorrhage, carbuncle, traumatic hemorrhage.
Flos Lonicerae is called Flos Lonicerae again, is described as the good medicine of heat-clearing and toxic substances removing from ancient times.The sweet cold fragrance of its property, clearing away heat with drugs sweet in flavor and cold in nature and not injuring one's stomach, fragrance reaches thoroughly and can be eliminating evil.Flos Lonicerae can dispelling wind-heat, and also kind removing summer-heat blood poison is used for various febrile diseases, and as fever of the body, dermexanthesis, send out cards such as speckle, pyretic toxicity carbuncle sore, laryngopharynx swelling and pain, all effect is remarkable.Pharmacological research shows that the effective ingredient in the Flos Lonicerae mainly contains three aspect effects: the one, and antibiotic and antiviral.Promptly staphylococcus aureus, Hemolytic streptococcus, dysentery bacterium, Bacillus typhi, meningococcus, Diplococcus pneumoniae, bacillus pyocyaneus and influenza virus etc. all there is obvious inhibitory action.The 2nd, the function of enhance immunity is arranged.Flos Lonicerae can promote lymphocyte transformation, strengthens leukocytic phagocytic function.The 3rd, antiinflammatory, analgesic.Flos Lonicerae can promote the release of adrenocortical hormone, and inflammation is had obvious inhibitory action.
Radix Notoginseng, hemostasis, analgesia.
Radix Angelicae Sinensis is enriched blood and is invigorated blood circulation, loosening bowel to relieve constipation.Be used for blood deficiency and yellow complexion, dizzy cardiopalmus, asthenia cold abdominalgia, dryness of the intestine constipation, rheumatic arthralgia, injury from falling down, ulcer sores
Fructus Citri Sarcodactylis, liver-smoothing, qi-regulating, and stomach and alleviating pain.Be used for stagnation of liver-QI and stomach-QI, distending pain in the chest and hypochondrium, gastral cavilty feeling of fullness, lack of appetite vomiting.
Concha Arcae reduces phlegm, softening the hard mass, dissipating blood stasis, removing food stagnancy.Control accumulation of phlegm, stomachache, noisy, acid regurgitation ， mass in the abdomen, scrofula, ulcerative gingivitis.
Herba Taraxaci, heat-clearing and toxic substances removing can be used for pyretic toxicity card, kind especially removing heat from the liver, treatment liver-heat conjunctival congestion and swelling pain, and multiple infection, purulent disease.Eliminating carbuncle eliminating stagnation treatment pyretic toxicity is stopped up the carbuncle sore tumefacting virus of tying due to the muscle, hyperpyrexia.Acute mastitis there is good effect, energy detoxicating and resolving stagnation of pathogens lactogenesis, oral administration or external application are often joined Flos Lonicerae and are equal to usefulness.Also can join Radix Et Rhizoma Rhei, Cortex Moutan treatment acute appendicitis in addition.
Radix Rehmanniae Preparata has the nourishing yin effect of enriching blood.
Rhizoma Coptidis, heat clearing and damp drying, eliminating fire and detoxication.Be used for damp and hot feeling of fullness, the vomiting acid regurgitation, dysentery, jaundice, unconsciousness due to high fever, hyperactivity of heart-fire, dysphoria and insomnia, heat in blood is told nosebleed, conjunctival congestion, the carbuncle furuncle is quenched one's thirst in toothache; External treatment eczema, eczema, auditory meatus is suppurated.The kind clear part of the body cavity above the diaphragm housing the heart and lungs of Rhizoma Coptidis (processed with wine) is burning hot.Be used for conjunctival congestion, aphtha.Prepared RHIZOMA COPTIDIS with rhizoma zingiberis recens juice clearing stomach stomach function regulating preventing or arresting vomiting.Be used for cold and heat and tie mutually, damp and hot middle resistance, feeling of fullness vomiting.Cornel Rhizoma Coptidis soothing liver-QI stomach function regulating preventing or arresting vomiting.Be used for incoordination between the liver and stomach, the vomiting acid regurgitation.
Radix Et Rhizoma Rhei has discharge function, and anti-bacteria and anti-virus reduces serum urea nitrogen and anastalsis.
Endothelium Corneum Gigeriae Galli, removing food stagnancy stagnates, strengthening the spleen and stomach.Control the food stagnation distension, vomiting regurgitation, dysentery, infantile malnutrition is quenched one's thirst, incontinence of urine, sore throat tonsillitis, ulcerative gingivitis aphtha.
Poria, the property slightly sweet flavor is flat, goes into the heart, lung, spleen channel.Has eliminating dampness and diuresis, invigorating the spleen and regulating the stomach, the effect of mind tranquilizing and the heart calming.
Fructus Evodiae, warming middle-JIAO, pain relieving is regulated the flow of vital energy, dampness, the contrary acid regurgitation of stopping vomiting, headache due to JUE YIN disorder, the coldness of ZANG-organ is vomited and diarrhoea, abdominal distention, abdominal pain during menstruation is had loose bowels just before dawn, vascular hypertension, beriberi, hernia, aphthous ulcer, toothache, eczema, impetigo.
Radix Cynanchi Paniculati, Xin Wen, row loose warm logical, energy functions dispelling wind and clearing away cold, removing dampness, promoting blood circulation and stopping pain.
The Rhizoma Pinelliae, drying dampness to eliminate phlegm; Stopping nausea and vomiting by lowering the adverse flow of QI; Dissolving lump and resolving mass.
Fructus Tsaoko, dampness is removed cold, the preventing the attack (or recurrence) of malaria that eliminates the phlegm, the random treating malaria disease of helping digestion, phlegm retention feeling of fullness, coldness and pain in the epigastrium, regurgitation, vomiting, dysentery, food stagnation.
The present invention is an ecosystem Chinese medicine, authentic medicinal herbs, and ancient method is developed, and has fully guaranteed the natural sex of medicine.Confirm by a large amount of clinical practices and experimental study, active ingredient of the present invention is evenly distributed on stomach (esophagus) mucomembranous surface, strong with stomach (esophagus) mucosa affinity, drug absorption is fast, have and improve environment in the digestive tract more by force, promote the probiotics growth, regulate nervimuscular function, facilitating digestion absorbs and improves gastric motility.Simultaneously can effectively improve and eliminate the gastral cavilty distending pain, treat superficial gastritis, chronic gastritis, and epigastric discomfort, nausea and vomiting, glutted, acid regurgitation, belch, suffer from diarrhoea, have the hiccups and disease such as burn feeling; Wherein contained antipathogenic composition can suppress and kill helicobacter pylori and eliminate mucosal inflammation, thereby promptly by improving the reverse wriggling of sphincteral contractile function of pylorus (cardia) and inhibition duodenum (stomach), solve the anti-stream of gastric juice and duodenal juice, the treatment reflux esophagitis, bile reflux gastritis, duodenitis, and the upper abdomen distending pain that therefore causes, stomach is glutted, bitter taste, two side of body distending pains, chest and back pain, burn, have the hiccups, belch, pharyngeal discomfort, stomachache, symptoms such as pantothenic acid, its composition principle and curative effect of medication are to the simple inhibiting challenge of Western medicine, can only relief of symptoms thereby rewritten reflux esophagitis and bile reflux gastritis, incurable history; Kinds of traditional Chinese medicines among the present invention has good antiinflammation, effectively stop the atrophy of gastric gland body, prevent the intestinal epithelial metaplasia and the atypical hyperplasia of gastric gland body simultaneously, effectively reduce the canceration rate of atrophic gastritis, the digestive functional disturbance of improving the gastric acid deficiency and causing, thereby radical cure atrophic gastritis and Pi Huasheng.All medicines share jointly and play, stomach and duodenal mucosa there are very strong protection and repair, repairing ulcer, the protection gastric mucosa, adjust the effect of gastrointestinal and vegetative nerve function, suppress pepsinogen and be transformed into protease, thereby reduce pepsic activity, the protection gastric mucosa stops ulcer, wherein contained Chinese medicine ingredients, can make congestion go new flesh to give birth to, it is evil fully to remove the blood system poison, blood stasis dispelling, more ulcer is treated chronic erosive gastritis, duodenal ulcer (ball inflammation), peptic ulcer, gastrorrhagia, duodenitis, abdominal pain, belch, heartburn; Can brute force kill pathogenic bacterium again, protect normal bacterium, antidiarrheal pain relieving fast; correct bowel dysfunction; improve the intestinal blood circulation, adjusting maincenter, sympathetic, intestinal function of nervous system activate intestinal mucosa cells regeneration; repair intestinal mucosa rapidly; recover stomach secretion, digestion, absorption function comprehensively, thereby can take effect in a short time, the treatment chronic gastritis; reach treating both the principal and secondary aspects of a disease, the purpose of stopping to recur.
Facts have proved: the present invention is improving the gastric mucosa resistance against diseases, is reducing gastric acid secretion, is eliminating mucosal inflammation, is promoting rotten to the corn face healing, is removing gastroptosis, is suppressing aspects such as bile reflux better curative effect is arranged, thereby radical cure gastric acid, flatulence, the belch of having a stomachache, have the hiccups, digests and assimilates poor, a series of digestive system disease such as health is become thin, constipation halitosis.
The present invention is a pure Chinese medicinal preparation, and toxic and side effects is little, is used for the treatment of peptic ulcer cure rate height, the medicine source is wide, cost is low, be worth clinical application.
The specific embodiment
Embodiment 1
3 parts of Endoconcha Sepiaes, 3 parts of Cortex Magnoliae Officinalis, 6 parts of Fructus Amomis, 3 parts of Rhizoma Corydalis, 6 parts of Herba Eupatoriis, 3 parts of the Radix Aucklandiae, 3 parts of Radix Paeoniae Alba (parched)s, 6 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 3 parts of Flos Loniceraes, 3 parts of Radix Notoginseng, 10 parts of Radix Angelicae Sinensis, 6 parts of Fructus Citri Sarcodactylis, 3 parts of Concha Arcaes, 3 parts of Herba Taraxacis, 6 parts in Radix Rehmanniae Preparata, 3 parts of Rhizoma Coptidis, 3 parts of Radix Et Rhizoma Rhei, 3 parts of Endothelium Corneum Gigeriae Galli, 6 parts in Poria, 3 parts of Fructus Evodiaes, 3 parts of Radix Cynanchi Paniculatis, 3 parts of 3 parts of the Rhizoma Pinelliaes and Fructus Tsaokos.
Raw material of Chinese medicine is worn into powder according to the above ratio, cooperate adjuvant to be prepared into capsule.
Embodiment 2
1 part of Endoconcha Sepiae, 5 parts of Cortex Magnoliae Officinalis, 3 parts of Fructus Amomis, 5 parts of Rhizoma Corydalis, 3 parts of Herba Eupatoriis, 5 parts of the Radix Aucklandiae, 1 part of Radix Paeoniae Alba (parched), 10 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 1 part of Flos Lonicerae, 5 parts of Radix Notoginseng, 5 parts of Radix Angelicae Sinensis, 10 parts of Fructus Citri Sarcodactylis, 1 part of Concha Arcae, 5 parts of Herba Taraxacis, 3 parts in Radix Rehmanniae Preparata, 5 parts of Rhizoma Coptidis, 1 part of Radix Et Rhizoma Rhei, 5 parts of Endothelium Corneum Gigeriae Galli, 3 parts in Poria, 5 parts of Fructus Evodiaes, 1 part of Radix Cynanchi Paniculati, 1 part of 5 parts of the Rhizoma Pinelliaes and Fructus Tsaoko.
Raw material of Chinese medicine is worn into powder according to the above ratio, cooperate adjuvant to be prepared into tablet.
Embodiment 3
5 parts of Endoconcha Sepiaes, 1 part of Cortex Magnoliae Officinalis, 10 parts of Fructus Amomis, 1 part of Rhizoma Corydalis, 10 parts of Herba Eupatoriis, 1 part of the Radix Aucklandiae, 5 parts of Radix Paeoniae Alba (parched)s, 3 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 5 parts of Flos Loniceraes, 1 part of Radix Notoginseng, 10 parts of Radix Angelicae Sinensis, 3 parts of Fructus Citri Sarcodactylis, 5 parts of Concha Arcaes, 1 part of Herba Taraxaci, 10 parts in Radix Rehmanniae Preparata, 1 part of Rhizoma Coptidis, 5 parts of Radix Et Rhizoma Rhei, 1 part of Endothelium Corneum Gigeriae Galli, 10 parts in Poria, 1 part of Fructus Evodiae, 5 parts of Radix Cynanchi Paniculatis, 5 parts of 1 part of the Rhizoma Pinelliae and Fructus Tsaokos.
Raw material of Chinese medicine is worn into powder according to the above ratio, cooperate adjuvant to be prepared into water pill.
Embodiment 4
With the capsule for treating peptic ulcer of embodiment 1 preparation, 30 minutes ante cibum of every day take medicine, and every day 3 times, all around a course of treatment, this side treats peptic ulcer 70 examples, 66 examples of fully recovering, produce effects 4 examples.
Therapeutic evaluation:
1. recovery from illness: remission, sign disappear, and gastroscope points out former ulcer to be the cicatrix phase or GI prompting niche disappears the OB feminine gender.
2. produce effects: sx, sign is slight or disappear, and gastroscope points out former ulcer source to dwindle or GI shows that niche shoals and dwindles.
3. do not heal: symptom fails to alleviate or aggravation, and gastroscope or GI prompting source of disease change little.
It should be noted that at last: obviously, the foregoing description only is for example of the present invention clearly is described, and is not the qualification to embodiment.For those of ordinary skill in the field, can also make other changes in different forms on the basis of the above description.Here need not also can't give exhaustive to all embodiments.And conspicuous variation of being extended out thus or change still are among protection scope of the present invention.
Claims (4)
1. Chinese medicine preparation that is used for the treatment of peptic ulcer, it is characterized in that: described Chinese medicine preparation is prepared from by following Chinese medicinal raw materials in portion by weight:
Endoconcha Sepiae 1-5 part, Cortex Magnoliae Officinalis 1-5 part, Fructus Amomi 3-10 part, Rhizoma Corydalis 1-5 part, Herba Eupatorii 3-10 part, Radix Aucklandiae 1-5 part, Radix Paeoniae Alba (parched) 1-5 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 3-10 part, Flos Lonicerae 1-5 part, Radix Notoginseng 1-5 part, Radix Angelicae Sinensis 5-10 part, Fructus Citri Sarcodactylis 3-10 part, Concha Arcae 1-5 part, Herba Taraxaci 1-5 part, Radix Rehmanniae Preparata 3-10 part, Rhizoma Coptidis 1-5 part, Radix Et Rhizoma Rhei 1-5 part, Endothelium Corneum Gigeriae Galli 1-5 part, Poria 3-10 part, Fructus Evodiae 1-5 part, Radix Cynanchi Paniculati 1-5 part, Rhizoma Pinelliae 1-5 part and Fructus Tsaoko 1-5 part.
2. the Chinese medicine preparation that is used for the treatment of peptic ulcer as claimed in claim 1 is characterized in that: described Chinese medicine preparation is prepared from by following Chinese medicinal raw materials in portion by weight:
1 part of Endoconcha Sepiae, 5 parts of Cortex Magnoliae Officinalis, 3 parts of Fructus Amomis, 5 parts of Rhizoma Corydalis, 3 parts of Herba Eupatoriis, 5 parts of the Radix Aucklandiae, 1 part of Radix Paeoniae Alba (parched), 10 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 1 part of Flos Lonicerae, 5 parts of Radix Notoginseng, 5 parts of Radix Angelicae Sinensis, 10 parts of Fructus Citri Sarcodactylis, 1 part of Concha Arcae, 5 parts of Herba Taraxacis, 3 parts in Radix Rehmanniae Preparata, 5 parts of Rhizoma Coptidis, 1 part of Radix Et Rhizoma Rhei, 5 parts of Endothelium Corneum Gigeriae Galli, 3 parts in Poria, 5 parts of Fructus Evodiaes, 1 part of Radix Cynanchi Paniculati, 1 part of 5 parts of the Rhizoma Pinelliaes and Fructus Tsaoko.
3. the Chinese medicine preparation that is used for the treatment of peptic ulcer as claimed in claim 1 is characterized in that: described Chinese medicine preparation is prepared from by following Chinese medicinal raw materials in portion by weight:
5 parts of Endoconcha Sepiaes, 1 part of Cortex Magnoliae Officinalis, 10 parts of Fructus Amomis, 1 part of Rhizoma Corydalis, 10 parts of Herba Eupatoriis, 1 part of the Radix Aucklandiae, 5 parts of Radix Paeoniae Alba (parched)s, 3 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 5 parts of Flos Loniceraes, 1 part of Radix Notoginseng, 10 parts of Radix Angelicae Sinensis, 3 parts of Fructus Citri Sarcodactylis, 5 parts of Concha Arcaes, 1 part of Herba Taraxaci, 10 parts in Radix Rehmanniae Preparata, 1 part of Rhizoma Coptidis, 5 parts of Radix Et Rhizoma Rhei, 1 part of Endothelium Corneum Gigeriae Galli, 10 parts in Poria, 1 part of Fructus Evodiae, 5 parts of Radix Cynanchi Paniculatis, 5 parts of 1 part of the Rhizoma Pinelliae and Fructus Tsaokos.
4. the Chinese medicine preparation that is used for the treatment of peptic ulcer as claimed in claim 1 is characterized in that: described Chinese medicine preparation is prepared from by following Chinese medicinal raw materials in portion by weight:
3 parts of Endoconcha Sepiaes, 3 parts of Cortex Magnoliae Officinalis, 6 parts of Fructus Amomis, 3 parts of Rhizoma Corydalis, 6 parts of Herba Eupatoriis, 3 parts of the Radix Aucklandiae, 3 parts of Radix Paeoniae Alba (parched)s, 6 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 3 parts of Flos Loniceraes, 3 parts of Radix Notoginseng, 10 parts of Radix Angelicae Sinensis, 6 parts of Fructus Citri Sarcodactylis, 3 parts of Concha Arcaes, 3 parts of Herba Taraxacis, 6 parts in Radix Rehmanniae Preparata, 3 parts of Rhizoma Coptidis, 3 parts of Radix Et Rhizoma Rhei, 3 parts of Endothelium Corneum Gigeriae Galli, 6 parts in Poria, 3 parts of Fructus Evodiaes, 3 parts of Radix Cynanchi Paniculatis, 3 parts of 3 parts of the Rhizoma Pinelliaes and Fructus Tsaokos.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101440443A CN101791388B (en) | 2010-04-12 | 2010-04-12 | Traditional Chinese medicine preparation for treating peptic ulcer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101440443A CN101791388B (en) | 2010-04-12 | 2010-04-12 | Traditional Chinese medicine preparation for treating peptic ulcer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101791388A true CN101791388A (en) | 2010-08-04 |
| CN101791388B CN101791388B (en) | 2012-05-30 |
Family
ID=42584448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101440443A Expired - Fee Related CN101791388B (en) | 2010-04-12 | 2010-04-12 | Traditional Chinese medicine preparation for treating peptic ulcer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101791388B (en) |
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102370927A (en) * | 2010-11-04 | 2012-03-14 | 姚鹏贵 | Compound traditional Chinese medicine for treating stomach disease |
| CN102671098A (en) * | 2012-05-15 | 2012-09-19 | 宋协勘 | Traditional Chinese medicine for treating peptic ulcer |
| CN103211063A (en) * | 2013-05-09 | 2013-07-24 | 北京绿源求证科技发展有限责任公司 | Pabular health tea electuary for protecting gastric mucosa |
| CN103623388A (en) * | 2013-12-23 | 2014-03-12 | 李�杰 | Traditional Chinese medicine preparation for treating chronic gastritis and preparation method thereof |
| CN103720974A (en) * | 2014-01-16 | 2014-04-16 | 刘茂荣 | Traditional Chinese medicine formula for treating gastrointestinal bleedings |
| CN103735694A (en) * | 2014-02-12 | 2014-04-23 | 胡枫 | Traditional Chinese medicinal formula capable of relieving functional diarrhea and preparation method thereof |
| CN103751694A (en) * | 2014-02-20 | 2014-04-30 | 李鲁宁 | Traditional Chinese medicine for treating peptic ulcer bleeding |
| CN103933501A (en) * | 2014-03-22 | 2014-07-23 | 李双双 | Traditional Chinese medicine composition for treating gastritis verrucosa |
| CN104524413A (en) * | 2014-12-24 | 2015-04-22 | 宋晓华 | Traditional Chinese medicine decoction for treating peptic ulcer and preparation method thereof |
| CN104826060A (en) * | 2015-05-13 | 2015-08-12 | 龚灿锋 | Traditional Chinese medicine for treating ulcer of digestive system |
| WO2015149396A1 (en) * | 2014-03-31 | 2015-10-08 | 袁志贤 | Preparation of traditional chinese medicine for treating superficial gastritis and preparation method therefor |
| CN105327296A (en) * | 2015-12-12 | 2016-02-17 | 徐士杰 | Medicine for treating peptic ulcer and preparing method of medicine |
| CN105727136A (en) * | 2016-03-02 | 2016-07-06 | 金丽丽 | Medicine for treating peptic ulcer |
| CN106038887A (en) * | 2016-07-05 | 2016-10-26 | 山西忻州兴华皮肤病专科医院 | Traditional Chinese medicine for treating stomach disease with middle-jiao cold and dampness and upper-jiao fire syndrome |
| CN106075261A (en) * | 2016-07-04 | 2016-11-09 | 赵瑜飞 | A kind of Chinese medicine preparation treating gastropathy |
| CN106110164A (en) * | 2016-08-10 | 2016-11-16 | 北京科诺德医药科技有限公司 | A kind of oral Chinese medicine powder formale treating taste-blindness rate |
| CN104352784B (en) * | 2014-10-28 | 2017-08-04 | 冯秋 | It is a kind of to treat stomach and the Chinese patent drug of dudenal disease and preparation method thereof |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102940838B (en) * | 2012-09-19 | 2014-06-25 | 李颖博 | Traditional Chinese medicine composition for treating constipation |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101766790A (en) * | 2010-04-08 | 2010-07-07 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicine composite for treating chronic atrophic gastritis and preparation method thereof |
-
2010
- 2010-04-12 CN CN2010101440443A patent/CN101791388B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101766790A (en) * | 2010-04-08 | 2010-07-07 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicine composite for treating chronic atrophic gastritis and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 《中医药信息》 19980710 贺俭 中医药治疗消化性溃疡研究近况 , 第04期 2 * |
| 《陕西中医》 20000605 蒋中南等 HP相关性慢性胃炎、溃疡病的中西药治疗概况及进展 第21卷, 第06期 2 * |
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102370927A (en) * | 2010-11-04 | 2012-03-14 | 姚鹏贵 | Compound traditional Chinese medicine for treating stomach disease |
| CN102370927B (en) * | 2010-11-04 | 2016-03-09 | 姚鹏贵 | The herbal mixture for the treatment of gastropathy |
| CN102671098A (en) * | 2012-05-15 | 2012-09-19 | 宋协勘 | Traditional Chinese medicine for treating peptic ulcer |
| CN103211063A (en) * | 2013-05-09 | 2013-07-24 | 北京绿源求证科技发展有限责任公司 | Pabular health tea electuary for protecting gastric mucosa |
| CN103211063B (en) * | 2013-05-09 | 2014-03-19 | 北京绿源求证科技发展有限责任公司 | Pabular health tea granula for protecting gastric mucosa |
| CN103623388B (en) * | 2013-12-23 | 2016-01-06 | 李�杰 | A kind of Chinese medicine preparation for the treatment of chronic gastritis and preparation method thereof |
| CN103623388A (en) * | 2013-12-23 | 2014-03-12 | 李�杰 | Traditional Chinese medicine preparation for treating chronic gastritis and preparation method thereof |
| CN103720974B (en) * | 2014-01-16 | 2016-04-13 | 刘茂荣 | A kind of Chinese medicine composition for the treatment of gastrointestinal haemorrhagia |
| CN103720974A (en) * | 2014-01-16 | 2014-04-16 | 刘茂荣 | Traditional Chinese medicine formula for treating gastrointestinal bleedings |
| CN103735694A (en) * | 2014-02-12 | 2014-04-23 | 胡枫 | Traditional Chinese medicinal formula capable of relieving functional diarrhea and preparation method thereof |
| CN103751694A (en) * | 2014-02-20 | 2014-04-30 | 李鲁宁 | Traditional Chinese medicine for treating peptic ulcer bleeding |
| CN103933501A (en) * | 2014-03-22 | 2014-07-23 | 李双双 | Traditional Chinese medicine composition for treating gastritis verrucosa |
| WO2015149396A1 (en) * | 2014-03-31 | 2015-10-08 | 袁志贤 | Preparation of traditional chinese medicine for treating superficial gastritis and preparation method therefor |
| CN104352784B (en) * | 2014-10-28 | 2017-08-04 | 冯秋 | It is a kind of to treat stomach and the Chinese patent drug of dudenal disease and preparation method thereof |
| CN104524413A (en) * | 2014-12-24 | 2015-04-22 | 宋晓华 | Traditional Chinese medicine decoction for treating peptic ulcer and preparation method thereof |
| CN104826060A (en) * | 2015-05-13 | 2015-08-12 | 龚灿锋 | Traditional Chinese medicine for treating ulcer of digestive system |
| CN105327296A (en) * | 2015-12-12 | 2016-02-17 | 徐士杰 | Medicine for treating peptic ulcer and preparing method of medicine |
| CN105727136A (en) * | 2016-03-02 | 2016-07-06 | 金丽丽 | Medicine for treating peptic ulcer |
| CN106075261A (en) * | 2016-07-04 | 2016-11-09 | 赵瑜飞 | A kind of Chinese medicine preparation treating gastropathy |
| CN106038887A (en) * | 2016-07-05 | 2016-10-26 | 山西忻州兴华皮肤病专科医院 | Traditional Chinese medicine for treating stomach disease with middle-jiao cold and dampness and upper-jiao fire syndrome |
| CN106110164A (en) * | 2016-08-10 | 2016-11-16 | 北京科诺德医药科技有限公司 | A kind of oral Chinese medicine powder formale treating taste-blindness rate |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101791388B (en) | 2012-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101791388B (en) | Traditional Chinese medicine preparation for treating peptic ulcer | |
| CN101791387B (en) | Traditional Chinese medicine preparation for treating chronic gastritis | |
| CN102526616A (en) | Chinese medicinal herb pills for treating cholecystitis and gallstone | |
| CN102940673B (en) | Medicine composition for treating dyspepsia | |
| CN103977358A (en) | Oral traditional Chinese medicine for lowering lipid and protecting liver | |
| CN104173906A (en) | Traditional Chinese medicine composition for treating gastrectasia | |
| CN102091279B (en) | Traditional Chinese medicine composition for treating duodenal ulcer | |
| CN105214032A (en) | The solid dispersion tablet for the treatment of peptic ulcer | |
| CN101780220B (en) | Traditional Chinese medicine for treating chronic gastritis | |
| CN101342282A (en) | Chinese medicinal composition for treating gastropathy and preparation method | |
| CN101239162B (en) | Traditional Chinese medicine composition for treating stomach disease | |
| CN100381141C (en) | Chinese medicine for treating prostatic hyperplasia | |
| CN103638293B (en) | A kind of Traditional Chinese drug mixture for the treatment of bile reflux gastritis | |
| CN103610925B (en) | Treat Chinese herbal and crude drugs preparations of old gastropathy and preparation method thereof | |
| CN102861160A (en) | Traditional Chinese medicine hemorrhoid elimination decotion | |
| CN1255165C (en) | Traditional Chinese medicinal preparation for treating iternal-external ulcer and its preparation method | |
| CN101401899A (en) | Medicament for treating gastric, duodenal ulcer | |
| CN105749172A (en) | Medicament for treating gastric calculus and preparation thereof | |
| CN104984237A (en) | Traditional Chinese medicine composition and preparation method | |
| CN104958757A (en) | Pressure sore paste and preparation method thereof | |
| CN104352899A (en) | Traditional Chinese medicinal preparation for treating chronic gastritis | |
| CN104383403A (en) | Traditional Chinese medicinal composition for treating chronic gastritis | |
| CN104173973A (en) | Oral liquid for treating dysentery and preparation method of oral liquid | |
| CN103610934A (en) | Traditional Chinese medicine for treating pharyngitis | |
| CN107375809A (en) | A kind of Chinese medicine for treating constipation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120530 Termination date: 20150412 |
|
| EXPY | Termination of patent right or utility model |